Gene editing to treat transthyretin amyloidosis with cardiomyopathy3' education - Nov. 6, 2022 - Kiran Musunuru, MD, PhD - Philadelphia, PA, USA
This video was recorded during the AHA Scientific Sessions 2022 in Chicago, IL, USA.
Kiran Musunuru, MD, PhD - Philadelphia, PA, USA
This recording was developed under auspices of PACE-CME. Views expressed in the recording are those of the presenter and do not necessarily reflect the views of PACE-CME.